Nearly one million people in the U.S. are living with Parkinson's disease (PD). This number is expected to rise to 1.2 million by 2030. Parkinson's is the second-most common neurodegenerative disease after Alzheimer's disease.
Nearly 90,000 people in the U.S. are diagnosed with PD each year.
More than 10 million people worldwide are living with PD.
The increases with age, but an estimated four percent of people with PD are diagnosed before age 50.
Men are 1.5 times more likely to have Parkinson's disease than women.

The most effective at-home light therapy helmet for Parkinson's disease, Alzheimer's disease, Stroke, Dementia, Memory loss, Mental Illness and other cerebral diseases requiring physical therapy.

Using the helmet with 3 easy steps:

1). Wear helmet on your head.

2). Turn on the device.

3). Leave it on for 30 minutes.

There's no need for technical knowledge or any kind of struggle. ZJZK Led helmet requires no manual effort. Simply put it on your head, relax, and enjoy your day while the led treatment does its work.

810nm near-infrared light can penetrate the scalp and skull by about 1cm. Transcranial leds from the near infrared spectrum have been shown to provide anti-inflammatory and antioxidant effects. Heat shock proteins can also be added to prevent protein misfolding and unwanted synthesis; Has the potential to increase neuron regeneration and synaptic regeneration. 40Hz has proven to be particularly beneficial to the brain. According to studies, our brain cells communicate at a frequency of 40Hz. Research has found this frequency to demonstrate "promising" results in terms of increasing cognition, clarity and alertness.

Improved recovery from stroke in certain patients: One study conducted with stroke patients showed that 810 nm NIR light wavelengths provided neuroprotective benefits and improved recovery among sufferers of moderate to severe strokes. Five days after the stroke, there was significant improvement among those who had been treated with 810 nm light therapy, compared to those who hadn’t. Ninety days post-stroke, 70 percent of the treated patients had a successful outcome, compared with only 51 percent of the control group.

Interest in the ability of near-infrared light to support improvement in psychiatric disorders goes as far back as this 2009 pilot study co-authored by world-renowned red light therapy expert Michael Hamblin. Prescription drugs have long been recognized as having a limited ability to assist individuals suffering from psychiatric conditions, and often come with a host of unwanted side effects. In this study, 810 nm NIR light applied to the forehead was shown to help patients suffering from major depression and anxiety, with no adverse side effects.